Gamot API Pte. Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Gamot API Pte. Ltd. - overview
Established
2020
Location
Singapore, -, Singapore
Primary Industry
Healthcare
About
Based in Singapore, Gamot API Pte. Ltd. , operates as a holding company formed by private equity (PE) firm PAG along with PE funds CX Partners and Samara Capital to acquire Anjan Drug Private Limited.
Primary Industry
Healthcare
Sub Industries
Healthcare
Total Amount Raised
Subscriber access only
Gamot API Pte. Ltd. - timeline of key events
Gamot API Pte. Ltd. - financials
| Fiscal Year Ended | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | Mar 31, 2025 |
|---|---|---|---|---|---|
| Revenue (USD) | 21,715 | (1,417,925) | - | - | - |
| % Revenue Growth (YoY) | - | (6629.7%) | - | - | - |
| EBITDA (USD) | (979,613) | (2,767,955) | - | - | - |
| Operating Income (USD) | (979,613) | (2,767,955) | - | - | - |
| Operating Margin | (4511.2%) | 195.2% | - | - | - |
| % EBITDA Margin | (4511.2%) | 195.2% | - | - | - |
| NET Income (USD) | (979,613) | (2,767,955) | - | - | - |
| % Net Margin | (4511.2%) | 195.2% | - | - | - |
Gamot API Pte. Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Anjan Drug Private Limited | - |
Displaying 1 - 1 of 1
Gamot API Pte. Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.